
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patien... ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.1068 | -6.54523950325 | 16.91 | 17.06 | 15.4 | 1688376 | 16.20431319 | CS |
4 | -0.9668 | -5.76505664878 | 16.77 | 17.2 | 15.4 | 2215355 | 16.31862343 | CS |
12 | -5.5568 | -26.0149812734 | 21.36 | 22.12 | 15.4 | 2374201 | 17.95449411 | CS |
26 | -1.8268 | -10.3618831537 | 17.63 | 23.64 | 15.33 | 3799819 | 18.46615892 | CS |
52 | 10.5532 | 201.013333333 | 5.25 | 23.64 | 5.02 | 3471170 | 14.39777595 | CS |
156 | 14.1482 | 854.876132931 | 1.655 | 23.64 | 1.38 | 2822766 | 7.74407937 | CS |
260 | 12.2732 | 347.682719547 | 3.53 | 23.64 | 1.01 | 3226241 | 5.094055 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.